A diagnostic study of Lymphoseek (technetium Tc 99m tilmanocept) to demonstrate the imaging time of sentinel lymph node in malignant melanoma compared to Tc99m sulfur colloid (SC).
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2015
At a glance
- Drugs Tc 99m tilmanocept (Primary) ; Tc 99m sulfur colloid
- Indications Malignant melanoma
- Focus Diagnostic use
- 15 Dec 2015 Status changed from not stated to completed.
- 10 Dec 2015 New trial record
- 03 Dec 2015 According to the Navidea Biopharmaceuticals Inc. media release, results were presented at the Radiological Society of North America Annual Meeting (RSNA 2015).